Brief: Nova Eye Medical HY Net Loss Attributable A$5.4 Million
26/02/2025 01:33
Feb 26 (Reuters) - Nova Eye Medical Ltd EYE.AX: HY REVENUES FROM ORDINARY ACTIVITIES A$12.9 MILLION HY NET LOSS ATTRIBUTABLE A$5.4 MILLION Further company coverage: EYE.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment